These Australian shiraz won acclaim at international wine shows, shining a light on our ability to produce premium red wines.

ASX medtechs are taking brain diagnostics beyond the hospital or clinical settings to the front lines of care for better ...

As the gold bull run continues, investors and explorers are looking to promising domestic projects in Queensland.

Investment advisor Jason Coggins believes US markets face a tough slog, given the nation's 'go-to' economic status is ...

The ASX has managed to claw its way into a 0.16pc gain, led up by defensive stocks in Utilities and Industrials.

Locksley Resources surges on plans to explore near America's only rare earths mine. Gallium explorers explode as Rio produces ...

AI is changing the way people find info, including how they use search giant Google, and in turn, how Google makes money from ...

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility disorders.

The ASX wobbled as the Fed held its ground, ANZ slipped, Neuren raked in royalty cash, Orica shot up, and Pro Medicus locked ...

The heavily pre-treated patients showed median progression-free survival of 29 months, which meant their tumours didn’t get bigger. Overall survival was 32 months, with a “manageable” safety profile.

Hillgrove Resources (ASX:HGO) is on track to hit its 14,000t production guidance, positioning it to reap the rewards of high copper prices.

Home loans with longer interest-only periods, offering lower initial repayments, are appearing in Australia as housing costs climb.